NEW YORK (GenomeWeb News) – Toyota Tsusho America and Nippon Kayaku have formed a joint venture that will focus on discovering and selling novel biomarkers and biomarker-based tests for diabetes.
 
The new company, which is called GlycoMark and is located in Winston Salem, NC, and in New York, will sell the GlycoMark diabetes blood test, which the two companies previously commercialized together through a partnership. The GlycoMark test is used to guide management of diabetic patients and for clinical trials on diabetes drugs.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

American scientists find themselves once again warning the Trump administration not to dismiss science, the New Yorker report.

A new study suggests CRISPR could be used to save coral reefs from dying off, Forbes reports.

Researchers have found that the i-motif shape of DNA previously observed in the lab also exists in human cells, and that it may serve a purpose.

In PNAS this week: a genomic, transcriptomic, and metabolomic analysis of the tea plant, Arabidopsis thaliana's adaptations to specific local environments, and more.